INVENT Pharmaceuticals

INVENT Pharmaceuticals is a biotechnology startup dedicated to developing novel and innovative drugs for the prevention and treatment of serious diseases, with a focus on Cardiopulmonary and Renal diseases, Fibrotic diseases, Oral Antiviral therapeutics, and Neurodegenerative diseases such as Alzheimer's. The company is committed to inventing safer and highly effective small molecule oral drugs to help patients, utilizing a proprietary drug target-specific innovative drug design platform.

INVENT Pharmaceuticals is leveraging its expertise in G-Protein Coupled Receptors (GPCRs) to invent best-in-class and first-in-class drugs for unmet medical needs. GPCRs have conserved structures of seven transmembrane (7-TM)-spanning helices, and the company's approach aims to develop potent, target receptor-selective, and highly effective therapeutics that modulate these receptors as drug targets.

The startup operates in the Biotechnology, Health Care, and Pharmaceutical industries, positioning itself at the intersection of cutting-edge science and medical innovation. With a strong emphasis on excellence in scientific research and drug development, INVENT Pharmaceuticals is poised to make significant contributions to improving patients' lives through groundbreaking pharmaceutical advancements.